Inhibrx Biosciences, Inc. INBX Accumulated Depreciation
Accumulated Depreciation at other companies
Other financials
Where this comes from
Reported directly by Inhibrx Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment.
The official record: Inhibrx Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Inhibrx Biosciences, Inc.'s accumulated depreciation.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Inhibrx Biosciences, Inc.'s accumulated depreciation?
- Inhibrx Biosciences, Inc. (INBX) reported accumulated depreciation of $11.66M in Q1 2026.
- How has Inhibrx Biosciences, Inc.'s accumulated depreciation changed year-over-year?
- Inhibrx Biosciences, Inc.'s accumulated depreciation increased by 21.8% year-over-year, from $9.57M to $11.66M.
- What is the long-term trend for Inhibrx Biosciences, Inc.'s accumulated depreciation?
- Over 2 years (2023 to 2025), Inhibrx Biosciences, Inc.'s accumulated depreciation has grown at a 29.0% compound annual growth rate (CAGR), from $6.69M to $11.12M.
- What does accumulated depreciation mean?
- Total accumulated depreciation on property, plant, and equipment since acquisition — represents the consumed portion of asset useful lives.